The Conversation (0)
- WORLD EDITIONAustraliaNorth AmericaWorld
Jun 17, 2025
Top 4 Small-cap ASX Biotech Stocks of 2025
More Featured Articles and Inverviews
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its lead neuroprotective peptide candidate, ARG007 improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.
Latest News
Latest News
Outlook Reports
Featured Biotech Investing Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES